| Literature DB >> 23406920 |
Jun Lv1, Miao Liu, Yu Jiang, Li-Ming Li.
Abstract
OBJECTIVE: The aim of this study was to learn about the progress of the prevention and control of major non-communicable diseases (NCDs) in China from 1990 to 2009 and to determine what prevention and control gaps remain based on the opinions of a group of panellists.Entities:
Keywords: China; Delphi survey; developing countries; non-communicable diseases; prevention and control
Mesh:
Year: 2013 PMID: 23406920 PMCID: PMC3572215 DOI: 10.3402/gha.v6i0.20004
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
The response rates of a two-round Delphi survey by expert panellists
| Number of participants | |||
|---|---|---|---|
| Expert panels | Size of the panel ( | First-round n1 (%) | Second-round n2 (% |
| Comprehensive Prevention and Control of NCDs | 7 | 2 (28.6) | 2 (100.0) |
| Cardiovascular Disease | 8 | 3 (37.5) | 1 (33.3) |
| Cancer | 9 | 2 (22.2) | 1 (50.0) |
| Chronic Respiratory Diseases | 7 | 1 (14.3) | 1 (100.0) |
| Diabetes | 8 | 2 (25.0) | 0 (0.0) |
| Nutrition | 8 | 5 (62.5) | 4 (80.0) |
| Ageing | 5 | 3 (60.0) | 3 (100.0) |
| Oral Health | 12 | 2 (16.7) | 2 (100.0) |
| Total | 64 | 20 (31.3) | 14 (70.0) |
One of the seven panel members was one of the survey researchers and did not participate in the survey.
The denominator for the response rate in the second round is the number of respondents in the first round.
Summary of panellists’ ratings of the scientific studies on NCDs in 1990–1999 and 2000–2009 in the second round (N=14)
| Practical implementation | ||||
|---|---|---|---|---|
| Median (IQR) score | Importance | Y1990–1999 | Y2000–2009 | |
| A1 | On the morbidity and mortality frequency of disease | 9.00 (1.25) | 5.00 (2.25) | 7.00 (1.00) |
| A2 | On the prevalence of disease risk factors | 9.00 (1.25) | 5.00 (2.25) | 7.00 (0.50) |
| A3 | On the aetiology of and risk factor for disease | 8.00 (1.25) | 4.00 (3.00) | 6.00 (2.00) |
| A4 | On the disease diagnosis | 7.00 (1.25) | 5.00 (1.00) | 6.50 (2.00) |
| A5 | On the disease treatment | 8.00 (2.00) | 5.50 (1.00) | 7.00 (1.25) |
| A6 | On the disease rehabilitation | 7.00 (1.00) | 4.00 (1.50) | 5.00 (1.25) |
| A7 | On the lifestyle intervention | 9.00 (1.00) | 5.00 (1.00) | 7.00 (2.00) |
| A8 | On the public policy | 8.00 (1.25) | 4.00 (2.50) | 6.00 (2.00) |
| A9 | On the economic evaluation | 8.00 (1.00) | 3.00 (2.50) | 5.00 (2.00) |
| A10 | Basic research | 8.00 (1.50) | 5.00 (2.00) | 6.00 (0.75) |
| A11 | Clinical research | 8.00 (2.50) | 5.00 (2.00) | 6.00 (1.75) |
| A12 | Prevention research | 8.00 (1.50) | 5.00 (3.00) | 6.00 (2.50) |
| A13 | Translational research | 8.00 (1.50) | 4.00 (3.00) | 5.00 (1.75) |
Items added or revised in the second round.
Summary of panellists’ ratings of the national policy and multisector collaboration in 1990–1999 and 2000–2009 in the second round (N=14)
| Practical implementation | ||||
|---|---|---|---|---|
| Median (IQR) score | Importance | Y1990–1999 | Y2000–2009 | |
| F1 | Development | 8.00 (1.50) | 4.00 (2.00) | 6.00 (1.00) |
| F2 | Implementation | 9.00 (1.50) | 3.00 (2.00) | 5.00 (1.00) |
| F3 | Development | 9.00 (0.75) | 3.00 (2.00) | 5.00 (2.00) |
| F4 | Implementation | 9.00 (2.50) | 2.00 (1.00) | 4.00 (2.00) |
| F5 | Development | 8.50 (2.00) | 3.00 (2.00) | 4.50 (1.00) |
| F6 | Implementation | 9.00 (2.00) | 3.00 (2.00) | 4.00 (1.00) |
| F7 | Development | 9.00 (1.25) | 3.50 (2.00) | 6.00 (2.00) |
| F8 | In line with current best-available evidence | 9.00 (1.00) | 4.00 (2.00) | 6.00 (1.25) |
| F9 | Applicable to Chinese population | 9.00 (2.00) | 4.00 (2.00) | 5.50 (1.00) |
| F10 | Practical and operational | 9.00 (1.25) | 3.50 (1.00) | 5.50 (1.25) |
| F11 | Training for professionals to improve adherence to guidelines | 9.00 (1.25) | 4.00 (1.25) | 5.00 (0.25) |
| F12 | Practical implementation | 8.00 (1.25) | 3.00 (2.00) | 5.00 (2.00) |
| G1 | Public health facilities | 8.00 (1.00) | 3.50 (1.50) | 5.00 (1.00) |
| G2 | Healthcare facilities | 8.00 (1.50) | 3.00 (1.25) | 5.00 (1.00) |
| G3 | Non-healthcare sectors | 7.00 (2.25) | 2.50 (1.25) | 4.00 (0.50) |
| G4 | Public health facilities | 9.00 (1.00) | 4.00 (2.25) | 6.00 (1.00) |
| G5 | Healthcare facilities | 9.00 (1.25) | 4.00 (2.00) | 6.00 (1.25) |
| G6 | Establishment of effective coordination mechanisms between healthcare sectors and non-healthcare sectors | 8.00 (1.25) | 3.00 (2.00) | 4.00 (1.00) |
| G7 | Involvement of non-healthcare sectors in the campaigns or programmes for NCD prevention and control initiated by healthcare sectors | 8.00 (2.00) | 3.00 (1.25) | 4.00 (2.00) |
| G8 | Healthcare sector involvement in the policy-making and decision-making of non-healthcare sectors | 8.00 (1.50) | 3.00 (1.50) | 4.00 (1.00) |
| G9 | Policy and actual operation of non-healthcare sectors supporting healthy lifestyles, or at least not promoting unhealthy lifestyles | 8.00 (1.50) | 2.00 (1.00) | 4.00 (2.00) |
Items added or revised in the second round.
Summary of panellists’ ratings of the practise in NCDs prevention and control in 1990–1999 and 2000–2009 in the second round (N=14)
| Practical implementation | ||||
|---|---|---|---|---|
| Median (IQR) score | Importance | Y1990–1999 | Y2000–2009 | |
| B1 | Cancer | 8.00 (1.50) | 6.00 (1.50) | 7.00 (1.00) |
| B2 | Heart disease | 9.00 (2.00) | 6.00 (2.00) | 8.00 (1.00) |
| B3 | Cerebrovascular disease | 9.00 (2.00) | 6.00 (1.50) | 7.00 (2.50) |
| B4 | Type 2 diabetes | 9.00 (1.50) | 5.00 (1.00) | 7.00 (1.50) |
| B5 | Chronic obstructive pulmonary disease | 8.00 (2.25) | 5.00 (1.00) | 6.00 (1.50) |
| B6 | Tobacco use | 9.00 (2.25) | 4.00 (1.50) | 6.00 (1.50) |
| B7 | Unhealthy diet | 8.00 (1.50) | 4.00 (1.00) | 6.00 (1.00) |
| B8 | Physical inactivity | 8.00 (1.50) | 4.00 (2.00) | 5.00 (1.00) |
| B9 | Harmful use of alcohol | 7.00 (2.00) | 4.00 (2.00) | 5.00 (1.50) |
| C1 | Morbidity | 8.50 (1.25) | 4.00 (1.25) | 5.00 (1.00) |
| C2 | Mortality | 8.50 (2.25) | 5.00 (1.25) | 6.00 (2.00) |
| C3 | Behavioural risk factors | 8.00 (1.50) | 4.00 (1.25) | 5.00 (1.00) |
| C4 | Healthcare facilities | 8.00 (2.00) | 4.50 (3.00) | 6.00 (3.00) |
| C5 | Schools | 8.50 (2.00) | 4.00 (1.50) | 6.00 (1.00) |
| C6 | Workplaces | 8.00 (1.25) | 4.00 (1.00) | 5.00 (1.25) |
| C7 | Community | 9.00 (2.00) | 4.00 (2.25) | 6.00 (1.00) |
| C8 | Other public places | 7.00 (2.00) | 3.00 (2.50) | 5.00 (1.00) |
| C9 | Elderly adults | 8.00 (2.50) | 4.50 (1.50) | 6.00 (2.00) |
| C10 | Young adults | 8.00 (1.25) | 4.00 (2.00) | 5.00 (1.25) |
| C11 | Youth | 9.00 (2.00) | 4.00 (2.00) | 6.00 (2.50) |
| C12 | Dissemination of, e.g. leaflets, brochures, and posters | 6.00 (1.25) | 4.50 (1.00) | 6.00 (1.25) |
| C13 | Community health lectures | 7.00 (1.25) | 4.00 (1.25) | 6.00 (1.25) |
| C14 | Theme-day campaign | 6.50 (2.00) | 4.00 (1.25) | 6.00 (1.25) |
| C15 | Mass media channels | 9.00 (1.00) | 4.00 (1.25) | 6.00 (3.00) |
| C16 | Doctor-patient communication | 8.00 (2.25) | 4.00 (2.00) | 6.00 (2.00) |
| C17 | On diseases | 7.50 (2.00) | 4.50 (1.00) | 6.00 (1.25) |
| C18 | On lifestyle risk factors | 8.00 (1.25) | 4.00 (1.25) | 6.00 (1.00) |
| C19 | Economic evaluation of health communication programmes | 8.00 (1.00) | 3.00 (1.25) | 4.00 (1.00) |
| C20 | Educational messages in line with current best-available evidence | 8.00 (0.25) | 4.00 (2.25) | 5.00 (1.00) |
| C21 | Screening for disease | 8.50 (2.00) | 4.00 (2.00) | 6.00 (1.25) |
| C22 | Providing effective diagnosis, treatment and intervention for individuals identified through early screening | 8.00 (1.25) | 3.50 (1.25) | 5.00 (2.00) |
| C23 | Effectiveness evaluation of screening programmes | 8.00 (1.50) | 4.00 (1.00) | 5.00 (1.50) |
| C24 | Economic evaluation of screening programmes | 7.00 (1.00) | 4.00 (1.50) | 4.00 (2.00) |
| C25 | Intervention for high-risk populations | 8.50 (1.25) | 4.00 (1.00) | 4.00 (1.25) |
| C26 | Treatment of patients | 8.00 (2.25) | 5.00 (1.25) | 5.50 (2.25) |
| C27 | Rehabilitation of patients | 7.50 (1.50) | 3.00 (2.00) | 4.00 (2.00) |
| C28 | Patient self-management | 8.00 (1.25) | 4.00 (2.00) | 4.00 (2.50) |
| C29 | Treatment plan in line with current best-available evidence | 8.00 (2.25) | 4.50 (2.25) | 4.00 (3.25) |
| C30 | Standardisation of treatment and management | 8.50 (1.25) | 3.00 (1.50) | 4.00 (3.25) |
Summary of panellists’ ratings of the health workforce and finance in 1990–1999 and 2000–2009 in the second round (N=14)
| Practical implementation | ||||
|---|---|---|---|---|
| Median (IQR) score | Importance | Y1990–1999 | Y2000–2009 | |
| D1 | In urban healthcare facilities | 8.00 (1.75) | 3.00 (2.00) | 4.50 (2.75) |
| D2 | In rural healthcare facilities | 8.00 (1.00) | 2.50 (1.75) | 4.00 (2.50) |
| D3 | In public health facilities | 8.00 (1.75) | 3.00 (2.00) | 4.50 (2.75) |
|
| ||||
| D4 | Scientific research | 8.00 (1.00) | 4.00 (2.00) | 5.50 (1.25) |
| D5 | Practise in NCD prevention and control | 8.50 (1.00) | 4.00 (2.25) | 5.00 (1.00) |
| D6 | Leadership | 8.00 (0.00) | 4.00 (2.00) | 5.00 (2.00) |
|
| ||||
| D7 | Scientific research | 7.00 (1.00) | 3.00 (1.75) | 4.50 (2.50) |
| D8 | The practise of NCD prevention and control | 7.50 (1.75) | 3.00 (2.00) | 4.50 (2.75) |
| D9 | Leadership | 7.00 (2.00) | 3.00 (1.75) | 5.00 (1.75) |
|
| ||||
| E1 | Regular funds from central government | 9.00 (1.25) | 2.50 (1.00) | 5.00 (1.00) |
| E2 | Regular funds from local government | 9.00 (1.25) | 2.00 (1.00) | 4.00 (1.25) |
| E3 | Specific funds for particular programmes of government ministries | 8.00 (1.25) | 3.00 (1.50) | 5.00 (1.00) |
| E4 | Other sources of funds | 6.50 (2.50) | 3.00 (2.00) | 5.00 (2.50) |
|
| ||||
| E5 | Scientific research | 6.50 (2.00) | 4.00 (2.00) | 5.00 (1.75) |
| E6 | Lifestyle intervention | 8.00 (0.50) | 3.00 (1.00) | 5.00 (0.00) |
| E7 | Screening for disease | 8.00 (0.50) | 3.00 (1.00) | 5.00 (0.25) |
| E8 | Treatment of patients | 7.00 (2.00) | 4.00 (1.50) | 5.00 (1.00) |
| E9 | Rehabilitation of patients | 7.50 (1.25) | 3.00 (1.00) | 5.00 (1.25) |
| E10 | Economic evaluation of NCD prevention and control programmes | 7.00 (1.25) | 2.50 (1.25) | 4.00 (2.00) |
Items added or revised in the second round.